Physician profile
Collin Labak
NPI 1750840617
$3,382.75
in general payments reported to CMS, 2019-2025
15 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.79 · 2022: $1,331 · 2023: $1,072 · 2024: $608 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,014.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,110.78 | 2022-2024 | Cervical-Stim |
| Medtronic, INC. | $436.23 | 2022-2025 | Unid_pass, Mazor X System, Space-D System 5.5/6.0 Voyager Instrument Set |
| Nuvasive, INC. | $414.35 | 2023 | Xlif, Tlif, Simplify Cervical Artificial Disc |
| Globus Medical, INC. | $297.98 | 2023-2024 | Quartex, Sable, Elsa, Elsa Al/Atp |
| Stryker Corporation | $288.76 | 2022-2024 | Duramatrix, Adherus Autospray Et Dural Sealant, N/A |
| Si-Bone, INC. | $286.80 | 2023 | |
| Nexus Medical Technologies LLC | $173.72 | 2025 | |
| Microvention, INC. | $145.00 | 2024 | Lvis, Web Aneurysm Embolization System, Stent |
| Csl Behring | $67.76 | 2020-2023 | Kcentra |
| Alexion Pharmaceuticals, INC. | $56.88 | 2023-2024 | Ultomiris |
| Takeda Pharmaceuticals U.S.A., INC. | $27.56 | 2024 | Hyqvia |
| Ucb, INC. | $26.47 | 2023 | Briviact |
| Argenx US, INC. | $25.45 | 2025 | Vyvgart Hytrulo |
| Astrazeneca Pharmaceuticals LP | $13.22 | 2024 | Wainua |
| Avanir Pharmaceuticals, INC. | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Labak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.